LGALS3 and hydrops fetalis: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) study and the Framingham Offspring Cohort showed that raised plasma levels of galectin-3 increases the risk for new-onset HF and all-cause mortality, notwithstanding other clinical factors, including NP levels [60,61].